SCHEMBL25818463

SCHEMBL25818463

Clc1nc(-c2cccc(-c3ccc4cccc(-c5ccc6ccccc6c5)c4c3)c2)nc(-c2ccc3c(c2)oc2ccccc23)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.38
HCRTR1 O43613 1/20 0.36
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 3/20 0.35
CYP1A2 P05177 2/20 0.35
HSD17B10 Q99714 2/20 0.35
CYP2C19 P33261 1/20 0.35
RAB9A P51151 1/20 0.35
ATM Q13315 1/20 0.35
ALOX5 P09917 1/20 0.34
MAPT P10636 2/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
DUSP3 P51452 1/20 0.33
PLA2G10 O15496 1/20 0.33
PRKDC P78527 2/20 0.33
PIM1 P11309 2/20 0.33
HSD17B1 P14061 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25817784 0.92 ALDH1A1 (0.39) AHRHCRTR1ALDH1A1KDM4ECYP1A2
SCHEMBL25818438 0.92 AHR (0.44) AHRHCRTR1ALDH1A1KDM4ECYP1A2
SCHEMBL25818478 0.91 PLA2G2A (0.36) AHRALDH1A1KDM4ECYP1A2HSD17B10
SCHEMBL25818551 0.91 AHR (0.43) AHRHCRTR1ALDH1A1KDM4ECYP1A2
SCHEMBL24344277 0.91 ALOX5 (0.40) AHRHCRTR1ALDH1A1KDM4EALOX5
SCHEMBL24343407 0.90 ALDH1A1 (0.41) AHRHCRTR1ALDH1A1KDM4ECYP1A2
SCHEMBL22161546 0.88 AHR (0.39) AHRHCRTR1ALDH1A1KDM4ECYP1A2
SCHEMBL25818523 0.88 PLA2G2A (0.40) AHRALDH1A1KDM4ECYP1A2HSD17B10
SCHEMBL25818509 0.87 AHR (0.41) AHRALDH1A1KDM4ECYP1A2HSD17B10
SCHEMBL25818396 0.87 AHR (0.44) AHRHCRTR1ALDH1A1KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 AHR 971/4885HCRTR1 3557/4885ALDH1A1 1010/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 AHR 971/4885HCRTR1 3557/4885ALDH1A1 1010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.